Machine Learning Times
EXCLUSIVE HIGHLIGHTS
Our Last Hope Before The AI Bubble Detonates: Taming LLMs
  Originally published in Forbes To know that we’re in...
The Agentic AI Hype Cycle Is Out Of Control — Yet Widely Normalized
  Originally published in Forbes I recently wrote about how...
Predictive AI Must Be Valuated – But Rarely Is. Here’s How To Do It
  Originally published in Forbes To be a business is...
Agentic AI Is The New Vaporware
  Originally published in Forbes The hype term “agentic AI”...
SHARE THIS:
  • Dec 15, 2014
  • Comments Off on Video: Using Predictive Analytics to Empower Cancer Patients through “MyCancerJourney”
  • PAW Conference Videos
  • 6472 Views

11 years ago
Video: Using Predictive Analytics to Empower Cancer Patients through “MyCancerJourney”

 

This speaker session is from Predictive Analytics World for Business, October, 5–9, 2014 in Boston, MA:

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.

Comments are closed.

 Robert is an experienced technology developer, entrepreneur and executive with over 20 years of industrial experience in developing analytic models for healthcare (payers, providers, life sciences), financial services, private equity, professional sports, and manufacturing. Robert developed the firm’s healthcare analytics products including comparative effectiveness analysis and predictive analytics for clinical and economic outcomes. Robert has also held executive leadership across various privately held companies and startups. Robert holds an MBA with a focus on finance from Washington University, Olin School of Business, and a BS in Business Administration Regis University. He is an adjunct with the Hatchery Program,

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.

 Dr. Piccirillo is a Professor of Otolaryngology, Medicine, and Biostatistics and leads the Clinical Outcomes Research Office at Washington University School of Medicine in St. Louis. His National Institutes of Health-supported research interests include the importance of comorbidity in the care of cancer patients and evaluation of cancer statistics, the use of functional connectivity MRI to study chemotherapy-induced cognitive impairment, and the development of MyCancerJourney’s MyNavigator (Prognostigram) (web-based programs to empower cancer patients with tailored health information).

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.